8 September 2021 - MSD Australia has today welcomed the signing of a new Medicines Strategic Agreement between Medicines Australia and the Australian Government.

The new Medicines Strategic Agreement in relation to reimbursement, health technology assessment and other matters, will commence on 1 July 2022, and sets in place an ambitious reform agenda aimed at improving patient access to new and innovative medicines in Australia.

Read MSD press release